IFABP2 as a new prognostic biomarker for secondary non-response in rheumatoid arthritis.

Oscar Zaragoza-García,Ilse Adriana Gutiérrez-Pérez,Olivia Briceño,José Rafael Villafan-Bernal,José Eduardo Navarro-Zarza,Isela Parra-Rojas,Ramcés Falfán-Valencia,Iris Paola Guzmán-Guzmán

International immunopharmacology（2023）

引用 0|浏览8

暂无评分

摘要

IFABP2 serum levels are potentially a new biomarker predictive of secondary non-response to csDMARDs in RA, although our findings should be validated externally and in a larger cohort.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要